Clinical Trial Update: Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor [NA]

View source ↗

Summary

A completed clinical trial evaluated haploidentical (half-matched) related donor stem cell transplantation using Killer Immunoglobulin-like Receptors (KIR) in a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hematologic Malignancy | NA | Status: COMPLETED | Results posted: 2024-12-06